Cargando…

The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic

Detalles Bibliográficos
Autores principales: Syed, Maha N., Shin, Daniel B., Wan, Marilyn T., Winthrop, Kevin L., Gelfand, Joel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American Academy of Dermatology, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331500/
https://www.ncbi.nlm.nih.gov/pubmed/32622891
http://dx.doi.org/10.1016/j.jaad.2020.06.1014
_version_ 1783553339946958848
author Syed, Maha N.
Shin, Daniel B.
Wan, Marilyn T.
Winthrop, Kevin L.
Gelfand, Joel M.
author_facet Syed, Maha N.
Shin, Daniel B.
Wan, Marilyn T.
Winthrop, Kevin L.
Gelfand, Joel M.
author_sort Syed, Maha N.
collection PubMed
description
format Online
Article
Text
id pubmed-7331500
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher by the American Academy of Dermatology, Inc.
record_format MEDLINE/PubMed
spelling pubmed-73315002020-07-06 The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic Syed, Maha N. Shin, Daniel B. Wan, Marilyn T. Winthrop, Kevin L. Gelfand, Joel M. J Am Acad Dermatol Research Letter by the American Academy of Dermatology, Inc. 2020-11 2020-07-02 /pmc/articles/PMC7331500/ /pubmed/32622891 http://dx.doi.org/10.1016/j.jaad.2020.06.1014 Text en © 2020 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Letter
Syed, Maha N.
Shin, Daniel B.
Wan, Marilyn T.
Winthrop, Kevin L.
Gelfand, Joel M.
The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
title The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
title_full The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
title_fullStr The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
title_full_unstemmed The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
title_short The risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic
title_sort risk of respiratory tract infections in patients with psoriasis treated with interleukin 23 pathway–inhibiting biologics: a meta-estimate of pivotal trials relevant to decision making during the covid-19 pandemic
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331500/
https://www.ncbi.nlm.nih.gov/pubmed/32622891
http://dx.doi.org/10.1016/j.jaad.2020.06.1014
work_keys_str_mv AT syedmahan theriskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic
AT shindanielb theriskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic
AT wanmarilynt theriskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic
AT winthropkevinl theriskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic
AT gelfandjoelm theriskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic
AT syedmahan riskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic
AT shindanielb riskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic
AT wanmarilynt riskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic
AT winthropkevinl riskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic
AT gelfandjoelm riskofrespiratorytractinfectionsinpatientswithpsoriasistreatedwithinterleukin23pathwayinhibitingbiologicsametaestimateofpivotaltrialsrelevanttodecisionmakingduringthecovid19pandemic